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Background: Pain is a common problem after stroke and is associated with poor
outcomes. There is no consensus on the optimal method of pain assessment in
stroke. A review of the properties of tools should allow an evidence based approach
to assessment.
Objectives: We aimed to systematically review published data on pain assessment
tools used in stroke, with particular focus on classical test properties of: validity, reliability,
feasibility, responsiveness.
Methods: We searched multiple, cross-disciplinary databases for studies evaluating
properties of pain assessment tools used in stroke. We assessed risk of bias using the
Quality Assessment of Diagnostic Accuracy Studies tool. We used a modified harvest
plot to visually represent psychometric properties across tests.
Results: The search yielded 12 relevant articles, describing 10 different tools (n= 1,106
participants). There was substantial heterogeneity and an overall high risk of bias. The
most commonly assessed property was validity (eight studies) and responsiveness the
least (one study). There were no studies with a neuropathic or headache focus. Included
tools were either scales or questionnaires. The most commonly assessed tool was the
Faces Pain Scale (FPS) (6 studies). The limited number of papers precluded meaningful
meta-analysis at level of pain assessment tool or pain syndrome. Even where common
data were available across papers, results were conflicting e.g., two papers described
FPS as feasible and two described the scale as having feasibility issues.
Conclusion: Robust data on the properties of pain assessment tools for stroke are
limited. Our review highlights specific areas where evidence is lacking and could guide
further research to identify the best tool(s) for assessing post-stroke pain. Improving
feasibility of assessment in stroke survivors should be a future research target.
Systematic Review Registration Number: PROSPERO CRD42019160679
Available online at: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD4
2019160679.
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INTRODUCTION
Pain is a common problem after stroke (1). Estimates of
the frequency of pain vary across studies, depending on the
population assessed and whether the focus is incident or
prevalent pain. Large cohorts of mild to moderate stroke
survivors suggest pain incidence of around 10% (2), while in
smaller cohorts figures range from 30% during the first months
(3), to 48% at 1 year (4) and 43% at 10 years (5) after stroke.
Post-stroke pain is associated with disability and reduced
quality of life (1). It is independently associated with fatigue
(6), depression (7) and has been strongly linked with suicidality
(8, 9). Pain after stroke can have a variety of etiologies and
manifestations, including: shoulder pain, headache, neuropathic
pain and exacerbation of pre-existing pain. Pain symptoms can
present at any point during stroke recovery and may progress to
chronic pain if not recognized and treated appropriately.
The first step in managing post-stroke pain is recognition
and measurement. However, management of pain has not always
been given the same priority as other aspects of stroke care
such as instituting secondary prevention (10). Pain assessment
is a complicated task made more challenging in the context of
stroke. Since pain is a subjective experience, self-report scales
and questionnaires are the most commonly employed pain
assessment tools in clinical practice and pain may be part of
a more general health related quality of life assessment (11).
However, stroke impairments such as cognitive decline and
communication issues may make it difficult for stroke survivors
to communicate the presence and experience of pain using these
tools (12, 13). Other impairments such as visual issues or loss of
motor skills may further complicate the use of self-completion
questionnaires or visual analog scales.
Accepting these caveats, there is a range of pain assessment
tools available that could be used with stroke survivors. Some
are generic, some are specific to a certain pain syndrome
and some are developed exclusively for stroke. At present
there is no consensus on the best approach to assessing
post-stroke pain and no standardized tool is recommended
for research or practice (14). In the absence of a gold
standard pain assessment in stroke survivors and with the
great variety of assessment tools available, clinicians may
struggle to know the most appropriate approach for their
patients. The choice of assessment tools should be guided
by evidence, particularly, the psychometric properties of
the pain assessment tools available. Classical test features
such as validity and responsiveness have been described for
certain pain tools, however, equally important are end-user
evaluations such as acceptability and feasibility within the
person’s healthcare setting.
A summary of psychometric properties of pain assessment
tools could help clinicians and researchers choose the most
appropriate measure, highlighting strengths and limitations and
also showing where new evidence is needed. Thus, we conducted
a systematic review to compare methods of pain assessment
following stroke with a particular focus on properties of validity,
reliability, feasibility, and responsiveness.
METHODS
We performed a systematic review, following best practice
(15) and where appropriate Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) reporting
guidance (16). Two assessors (SE, TQ) performed all aspects of
title selection, data extraction and analyses with disagreements
resolved through discussion.
As our focus was test properties, we structured our review
question using the format recommended for test accuracy
evidence synthesis (17).
• Index test: Any measure of pain that gives an objective
read out.
• Reference standard: Any measure that provides data on the
classical test properties of interest namely validity, reliability,
feasibility and responsiveness.
• Condition: Stroke of any kind and at any stage in
stroke journey.
• Setting: Any healthcare setting.
Search Strategy
We searched the following databases, chosen to represent the
various disciplines that may assess post-stroke pain: Medline
(Ovid), Embase (Ovid), CINAHL (EBSCO) and PsychInfo
(EBSCO). All were searched from inception to 1st May 2020.
Search concepts were “stroke” and “pain” and “assessment.” We
used validated search filters for “stroke” and “pain,” taken from
the relevant Cochrane review group (Supplementary Materials).
We complemented our search by contacting members of an
international stroke pain research group to ensure we had not
missed relevant studies.
We screened titles, abstracts and then full text to inform
decisions on inclusion. Forward and backward citation searching
was conducted for relevant studies using Web of Science
functionality. As a test of search validity, we pre-specified two
papers (one original research and one review) that should be
returned on our literature search (1, 18). As a further test we
cross-checked our included papers with a systematic review of
pain assessment in aphasia, recognizing that the topics were
distinct but were likely to have considerable overlap (14).
Selection Criteria
The population of interest was adult stroke survivors at any
stage of recovery. We did not include traumatic brain injury. If
a mixed population was included, stroke had to represent more
than 75% of the group. The test of interest was any form of pain
assessment, including scales, questionnaires, observations and
other patient reported outcome measures. Outcomes of interest
were psychometric properties of the tools as defined below. We
included studies of any quantitative design, conducted in any
healthcare setting, noting setting as part of our data extraction.
We only included studies published in peer reviewed journals but
applied no other restrictions.
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Data Collection Process and Data Items
We designed and piloted a bespoke data collection form. We
used the research paper that informed our internal validation for
piloting (18).
We collected data on the following:
Study details: publication date, country, study design (i.e.,
cross-sectional, prospective, retrospective), psychometric
properties assessed (validity, feasibility, intra/inter-reliability,
responsivity), sample size.
Stroke details: stroke classification (for example ischaemic
or haemorrhagic), time since stroke, setting (classified as:
acute stroke unit, rehabilitation, outpatient, community, using
descriptions in the original paper), inclusion/exclusion criteria in
original study, noting if there were specific exclusions relating to
language or cognition.
Pain assessment: type of pain (see below), method(s) of pain
assessment (i.e., pain scales, questionnaires, stroke specific or
generic), pain assessor(s) (i.e., researcher or clinical discipline).
For articles comparing multiple methods of pain assessment, we
included all tools and recorded the primary pain assessment tool.
Categorization of Pain Syndromes
We categorized pain using the following pre-specified labels:
neuropathic, nociceptive (noting the site i.e., lower limb),
headache or experimental (i.e., investigator induced pain). We
classified stroke shoulder pain as a distinct category as it can
include both nociceptive and neuropathic elements. Our pain
classification was based on the description in the original paper.
Where the nature of the pain syndrome was not clear, two
reviewers (SE, TQ) discussed and came to consensus. For some
papers, lack of detail precluded applying any label with certainty,
and these were categorized as ‘‘non-specified.”
Psychometric Properties
We were interested in the following psychometric properties:
validity, reliability, feasibility, responsiveness. These were defined
as (19, 20):
• Validity: the extent to which an instrument measures what
is intended, in this case, is the tool a measure of pain?
The concept of “accuracy” would be included as a measure
of validity.
• Reliability: the internal consistency of an instrument, and
the degree to which it is free from error on repeated.
We included measures of inter-observer, intra-observer and
internal reliability.
• Feasibility: usability, and acceptability of an instrument from
the perspective of assessors and those being assessed.
• Responsiveness: the ability of the instrument to distinguish
clinically important changes over time.
On initial scoping it became clear that a traditional quantitative
meta-analysis would not be possible, due to the substantial
clinical heterogeneity across studies in terms of populations
assessed, methods used, nature of pain assessments and
psychometric properties described. To allow cross-study
comparisons, we created summary measures of the study
findings at the level of the psychometric property studied. Our
categorization was based on the conclusions of the original paper
and was agreed by consensus of two assessors (SE, TQ). We
classified results as positive, neutral or inconclusive.
Risk of Bias
We assessed risk of bias for included studies at the outcome
level. Two (SE, TQ) investigators individually assessed papers and
agreed final grading. No single quality assessment tool would be
suitable for the variety of methodologies that were included in
our eligible papers. We elected to use the Quality Assessment of
Diagnostic Accuracy Studies 2 (QUADAS-2) tool (21). QUADAS-
2 is designed for assessing studies of test accuracy and uses a
framework suited to our review with assessment of bias and
applicability across four domains: patient selection, index tests,
reference standard, flow and timing (17). As recommended, we
took the original QUADAS-2 anchoring statements andmodified
to suit our review (modified domain questions included in
Supplementary Materials). We used robvis R package software
to create summary “traffic light” plots (22). Due to the limited
number of studies and heterogeneity in summary measures we
did not perform quantitative assessment for publication bias.
Evidence Synthesis
We created two summary tables (Tables 1, 2): the first
describes key characteristics of the included articles and
the second summarizes their quantitative results. Our data
were heterogeneous and required representation of differing
constructs across various axes. To allow a visual representation
that included pain syndrome, pain assessment tool and results
of psychometric testing across various constructs we developed
a visual plot using a modified harvest plot (23). We first
created a matrix that plotted results by pain assessment tool (we
created space in the plot for subcategorising by pain scales and
questionnaires) against each psychometric property of interest.
We color-coded according to pain type with one unit of plot space
per study/experiment and then assigned the results of the study
as positive (above a horizontal line of no effect), neutral (below
the line) or inconclusive (crossing the line).
RESULTS
The primary search yielded 2,851 articles, with 12 (9, 18, 24–
33) papers (n = 1,106 participants) meeting the inclusion
criteria (Figure 1). Our search results suggested a valid search
as they included the two pre-selected papers and had all the
relevant studies from the previous aphasia review. The number
of participants in eligible papers ranged from 19 to 388. The most
commonly employed design was cross-sectional (n= 6) with the
majority of studies (n = 6) conducted in a rehabilitation setting
(Table 1, Supplementary Materials).
In total, 10 different pain scales and questionnaires were
assessed across the 12 studies (Table 1). These were: Visual
Analog Scale (VAS [differing scales described as VAS]), the Faces
Pain Scale (including a revised version), Numerical Rating Scale,
and various combinations of these; the Pain Assessment Scale
for Seniors with Severe Dementia-II (PACSLAC-II), and three
questionnaires: AbilityQ, ShoulderQ and the neuropathic pain
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TABLE 1 | Key Characteristics of included papers.
Author/s Study design Psychometric
properties
assessed
Number
included
Age (years)
(mean, SD)
Stroke setting Exclusion criteria Type of pain Pain
assessment
tool
Pain assessor
1. Benaim (9) Cross-sectional Validity, reliability 127 63 ± 8 Rehabilitation cognitive impairments,
psychiatric disorders
Shoulder pain FPS Unknown
2. Chuang (24) Prospective Reliability 50 52.6 ± 11.0 Outpatient other acute pain
conditions, major
medical problems,
psychological
impairments, aphasia
Arm/shoulder
pain
v-NPRS-FPS Clinical staff
(rehabilitation
physicians)
3. Dogan (25) Case control Validity 60 including
non-stroke control
(n = 30)
64.2 ± 9.42 Rehabilitation Pre-existing pain
conditions, cognitive
impairment, aphasia
Shoulder pain FPS Unknown
4. Korner-Bitensky
(26)
Cross-sectional Validity 90 Not available Rehabilitation cognitive impairments,
central post-stroke pain
syndrome
Experimental
(thermal)
10-cm v-VAS Clinical staff (SLT),
researcher
5. Price (18) Case control Feasibility, validity 144 including
non-stroke
controls (n = 48)
72.5 mean Acute stroke unit reduced conscious
level or dysphasic
Experimental
(pressure)
v/m/h-VAS Researcher
6. Smith (27) Retrospective Feasibility 388 77 (IQR:66–86) Acute stroke unit subsequent strokes Not specified FPS and/or
NRS
Clinical staff
(Nurses)
7. Roosink (28) Cross-sectional Validity 19 57.5 ± 7. 5 Rehabilitation other chronic pain
conditions, neurological
deficits
Shoulder pain DN4 Unknown
8. Turner-Stokes
(29)
Cross-sectional Validity, reliability,
feasibility
49 52.6 ± 3.1 Rehabilitation not specified Shoulder pain AbilityQ,
ShoulderQ
Researcher
9. Turner-Stokes
(30)
Retrospective Responsiveness 30 47.2 ± 2.2 Rehabilitation not specified Shoulder pain AbilityQ,
ShoulderQ
Clinical staff
(Nurses)
10. Mandysová
(31)
Cross-sectional Validity, reliability,
feasibility
80 71.0 ± 13.7
(range 22–94)
Acute stroke unit reduced conscious
level
Not specified VAS/NRS,
NRS, FPS-R
Researcher
11. Pomeroy (32) Prospective Reliability 33 74 (range 57–89) Community reduced conscious
level, other pain
conditions, no irregular
pain medication, no
neurological/MSK
disorders
Shoulder pain 10-cm v-VAS Clinical staff
(physiotherapist)
12. Soares (33) Cross-sectional Reliability, validity 36 61 median (range
46–71.75)
Acute stroke unit neurological disorders Experimental
(mechanical)
PACSLAC-II Clinical staff
(Neurology nurses)
Study design and setting were categorized and agreed by two raters (SE, TQ).
FPS, Faces Pain Scale; NRS/NPRS, Numerical Rating Scale; VAS, Visual Analog Scale, v-/m-/h-, vertical/mechanical/horizontal.
NPRS-FPS and VAS/NRS indicate combined versions of scales DN4, neuropathic pain diagnostic questionnaire; PACSLAC-II, Pain Assessment Scale for Seniors with Severe Dementia-II.
SLT, Speech and Language Therapy.
N.B. more comprehensive version of table is available in Supplementary Materials.
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TABLE 2 | Summary of results from included articles.
Author/s Pain assessment
(comparator)
Results
1. Benaim (9) FPS (VAS, VRS) • Validity: Correlation of FPS with VAS and VRS in both left and right hemisphere stroke (r =
0.65–0.82)
• Reliability:
• Inter-rater:K:0.64 (SE = 0.11) and K:0.44 (0.09) in left and right hemisphere stroke respectively.
• Intra-rater:K:0.74 (0.13) and K:0.53 (0.10) in left and right hemisphere stroke respectively.
• Feasibility: FPS was preferred in left hemisphere stroke, VAS was preferred in right
hemisphere stroke.
2. Chuang (24) v-NPRS-FPS • Reliability (intra-rater):ICC=0.82 (SE=0.81), [smallest real difference = 1.87].
• No significant systematic bias between repeated measurements for NPRS-FPS.
• High level of stability and minimal temporal variation, range of limits of agreement (−2.50 to 1.90)
3. Dogan (25) FPS (VAS, LPS, NRS) • Validity: Correlation of FPS with other pain scales in both groups (r = 0.95–0.97 and
0.67–0.93, respectively).
4. Korner-Bitensky (26) 10-cm v-VAS • Validity: No between group difference in pain discrimination (p = 0.75).
• Repeated-measures ANOVA revealed no effect of group.
5. Price (18) v/m/h-VAS FPRS, NRS • Feasibility: Range (proportion) of stroke survivors able to complete various versions of VAS 65–47%
(P < 0.001 in comparison to non-stroke controls)
• Range (proportion) of more severe stroke (TACS) able to complete various versions of VAS
28–14% (P < 0.001 in comparison to other strokes)
6. Smith (27) FPS, NRS • Feasibility: 13.4% individuals unable to provide a meaningful response to either FPS or NRS.
• Validity: Maximum NRS values correlated with length of stay (r = 0.29, P < 0.0001), stroke
severity (r = 0.212, P = 0.0008), and number of sites of pain (r = 0.20, P = 0.007).
7. Roosink (28) DN4 (NRS) • Validity: DN4+ classified patients reported: constant pain [DN4+:n = 4 (44%); DN4-:n = 0] higher
pain intensity [DN4+ = 4.7 (SD = 2.9); DN4- = 2.5 (SD = 2.4)] higher impact of pain on daily living
DN4+ = 5.9 (SD = 4.8), DN4- = 2.0 (SD = 2.6) more frequent loss of cold sensation [DN4+: n =
7 (78%); DN4-: n = 2 (20%)]
• Signs and symptoms suggestive of neuropathic or nociceptive pain corresponded to DN4+ and
DN4- respectively.
8. Turner-Stokes (29) AbilityQ, ShoulderQ
(VAS)
• Validity: VAS agreement± 1 on a 10-point scale was 36–59%with intraclass correlation coefficients
0.50–0.60 (p < 0.01).
• Reliability: Agreement for individual questions 55–88%; K:0.07–0.79
• Repeatability of ShoulderQ 36–72%, K: 0.16–0.56.
• Feasibility: N = 31 (63%) required help in completing AbilityQ.
9. Turner-Stokes (30) AbilityQ, ShoulderQ
(VGRS)
• Responsiveness: Changes on VGRS associated with verbal reports of improvement (r: 0.67, P <
0.001).
• Responders demonstrated significant change in VGRS and verbal scores, whereas non-responder
group did not.
• A change in summed VGRS score of ≥3 showed 77% sensitivity and 91.3% specificity for
identifying responders, with a positive predictive value of 93.3%. Summed VGRS scores of ≤2
had a negative predictive value of 73.3%.
10. Mandysová (31) VAS/NRS, NRS, FPS-R • Validity: n = 19 (24%) reported pain using at least one scale.
• Spearman correlation was 0.997 (p < 0.001) between VAS/NRS and NRS.
• Feasibility: NRS had the highest preference ranking (ranking first or second in 75% cases).
11. Pomeroy (32) 10-cm v-VAS • Inter-rater reliability: ICC:0.79 for intensity, 0.75 for frequency and 0.62 for affective response.
• Wide limits of agreement and significant rater bias reported for 6/27 ratings.
• Intra-rater reliability:ICC:0.70 for intensity, 0.77 for frequency and 0.69 for affective response.
12. Soares (33) PACSLAC-II • Validity: PACSLAC-II differentiated 4.5-lb stimulus versus 2-lb (p = 0.03) or 0lb (p = 0.05).
• Reliability (internal): Cronbach α:0.87, 0.94, and 0.96 for weights of 0, 2, and 4.5 lb, respectively.
FPS, Faces Pain Scale; NRS/NPRS, Numerical Rating Scale; VAS, Visual Analog Scale; LPS, Likert Pain Scale; FPRS, Four-point rating scale; v-/m-/h-, vertical/mechanical/horizontal,
visual graphic rating scale (VGRS); NPRS-FPS and VAS/NRS indicate combined versions of scales DN4=neuropathic pain diagnostic questionnaire (DN4+, neuropathic pain reported;
DN4-, no neuropathic pain reported); PACSLAC-II, Pain Assessment Scale for Seniors with Severe Dementia-II.
diagnostic questionnaire (DN4). Of the included assessments,
only the ShoulderQ was developed specifically for stroke. The
Faces Pain Scale was the most commonly reported, with a version
of this scale used in six of the 12 studies.
Where a pain category was described, the most commonly
studied was shoulder pain. Neuropathic pain and Headache
were not studied, except possibly in those papers that did not
differentiate pain type. There was heterogeneity in the tools
assessed for each pain category, with no pain category having
more than two studies using a common tool (Table 3).
There was a high risk of bias detected in the majority of
included papers (n= 8; Figure 2). Highest risk of bias and issues
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FIGURE 1 | PRISMA Flow chart for selection of studies for systematic review. The first search was performed on 31st July 2019; to ensure the review was up to date
we ran a repeat search on 08/05/2020. The PRISMA contains an aggregate of both searches.
TABLE 3 | Cross-tabulation of pain assessment tool and post stroke pain syndrome.
Pain assessment tool
VAS VAS-NRS FPS FPS-NRS NRS VRS ShoulderQ PACSLAC-11 DN4
Post-stroke pain syndrome Shoulder/arm pain 1 0 2 1 0 0 2 0 1
Experimental 2 0 0 0 0 0 0 1 0
Not specified 0 1 2 0 2 0 0 0 0
Neuropathic 0 0 0 0 0 0 0 0 0
Headache 0 0 0 0 0 0 0 0 0
Each value represents use of a pain assessment tool by according to a post-stroke pain syndrome.
FPS, Faces Pain Scale; NRS/NPRS, Numerical Rating Scale; VAS, Visual Analog Scale; LPS, Likert Pain Scale; FPRS, Four-point rating scale; v-/m-/h-, vertical/mechanical/horizontal,
visual graphic rating scale (VGRS), NPRS-FPS and VAS/NRS indicate combined versions of scales DN4, neuropathic pain diagnostic questionnaire (DN4+, neuropathic pain reported;
DN4-, no neuropathic pain reported); PACSLAC-II, Pain Assessment Scale for Seniors with Severe Dementia-II.
with generalisability was seen for the domain of patient selection
(n = 10; judged high risk). This was due to exclusion of patients
for whom pain assessment would be expected in clinical practice,
including those with pre-stroke pain (n = 5 papers), aphasia
(n = 3) and cognitive impairment (n = 3). There was poor
reporting of studymethods relevant to the risk of bias assessment,
particularly around blinding of results when a study compared
scales. Only four papers were judged to have overall low risk of
bias (18, 24, 32, 33).
We created a visual synthesis of the psychometric properties of
the tools used to assess pain as a modified harvest plot (Figure 3).
The harvest plot approach allows visual display of data across
several axes in one figure. We represented each study as a single
unit (square), and color coded based on pain type. A horizontal
line that bisected each row was a line of uncertain effect, if a study
claimed that the psychometric property of interest was “good”
i.e., acceptable for clinical use then the study was placed above
the line, if the paper reported that the study was “poor” i.e., would
not be suitable it was placed below the line.
All psychometric domains of interest were reviewed by at least
one study, although the statistical approach to these assessments
varied. Validity was the psychometric property evaluated most
frequently (n = 8), and responsiveness was only considered by
one study. In general the pain scales assessed were judged to
be valid measures by the authors of the studies, with only two
studies reporting concerns around validity (Figure 3). A version
of the Faces Pain Scale was the most commonly assessed, with
evaluations of validity (n = 3), reliability (n = 3), and feasibility
Frontiers in Neurology | www.frontiersin.org 6 August 2020 | Volume 11 | Article 792
Edwards et al. Pain Assessment in Stroke
FIGURE 2 | Traffic Light plot for risk of bias in individual studies.
(n= 2). However, results were conflicting, for example feasibility
of FPS was assessed as good, neutral and poor across the studies
(Figure 3).
DISCUSSION
We aimed to systematically review the psychometrics of pain
assessment tools when used with stroke survivors. We found a
limited literature with substantial heterogeneity in the tools used,
the research methods employed and the properties assessed. The
available data were limited by risk of bias and modest sample
sizes. Thus, we are unable to recommend a preferred tool based
on published psychometric properties. However, through our
evidence synthesis, we have highlighted important evidence gaps
that can inform the direction of future research activity in the
pain assessment space.
Our mapping of the evidence using the harvest plot
demonstrates the many limitations in the evidence base. Of the
four key psychometric properties, there was little information on
reliability, and responsiveness. Even where there was a portfolio
of papers on a single tool it was difficult to draw conclusions.
There were more studies on visual scales than questionnaires,
with few studies using a scale specifically developed for stroke and
no studies with a neuropathic or headache pain focus.
Our findings of inconsistent and inconclusive evidence are not
unique to stroke. A previous review of pain assessment in aphasia
concluded that “a feasible, reliable and valid pain assessment
instrument is not yet available” (14). Dementia is another clinical
condition where pain is common but potentially difficult to
assess. Although there is more published literature on dementia
pain assessment tools (34), conclusions of reviews are similar
“limited evidence about reliability, validity and clinical utility”
(35). This seems a missed opportunity, as well as the clinical
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FIGURE 3 | Harvest plot of psychometric evaluation of pain scale according to the 12 included studies. Each unit represents a differing study. Color coding is used to
represent differing pain types. Position around horizontal line describes paper conclusions regarding the property of interest, where above the line indicates “good,”
below the line indicates “poor” and on the line indicates “uncertain.” Full description given in main manuscript. VAS, Visual Analog Scale; NRS, Numerical Rating
Scale; FPS, Faces Pain Scale; VRS, Visual Rating Scale; ShoulderQ, Shoulder pain questionnaire; PACSLAC-II, Pain Assessment Scale for Seniors with Severe
Dementia-II; DN4, neuropathic pain diagnostic questionnaire.
importance of looking for pain, quantitative pain assessment
could be a useful research outcome (36).
Our assessment of risk of bias suggests common areas
of concern particularly around reporting and generalisability.
Exclusion of stroke survivors with aphasia, dementia or
comorbidity threatens the external validity of study results.
Similar exclusions have been demonstrated in other aspects of
stroke assessment (37). Certain scales may not be suitable for all
stroke impairments, but simply excluding those people who may
struggle to complete an assessment creates bias in any resulting
estimates (38).
Our review has several strengths. We performed a
comprehensive search, followed best practice guidance and
embedded internal validation steps. Given the disparate nature
of relevant studies, we used non-traditional methods for evidence
synthesis and assessment of quality. There are limitations to
our approach. Despite internal and external validity steps we
may have missed relevant papers. We were not able to perform
quantitative meta-analysis either at an aggregate level or at
the level of differing pain types, but instead used a relatively
novel method of visual data synthesis. Our modified harvest
plot approach gives a summary of the totality of the data across
various axes, allowing for visual comparisons across tools.
This approach could be applied in other complex reviews with
substantial heterogeneity in the supporting literature.
Despite the prevalence of post-stroke pain, studies describing
the best way to assess for this problem are limited in number and
quality. Our evidence mapping and quality assessments highlight
particular pain syndromes and tests that have no empirical
evidence base. No pain assessment had sufficient data to be
considered definitive and further, robust research for any pain
tool would be a welcome addition.
In light of this uncertainty what conclusions can be made?
Patient based scales, such as faces pain scale, seem to have the
most supporting evidence and are a valid means to assess pain.
Our review suggests there are many evidence gaps requiring
future research, but methods to improve feasibility of assessment
seem an important target.
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